ESC Professional Premium Access

Effect of alirocumab added to high-Intensity statin therapy on endothelial function in patients with acute myocardial infarction: A sub-study of the randomized placebo-controlled PACMAN-AMI trial

Congress Session

About the speaker

Doctor Emrush Rexhaj

University Hospital, Inselspital Bern, Bern (Switzerland)
1 presentation
0 follower

5 more presentations in this session

Patient knowledge about risk factors, achievement of target values and guideline adherent secondary prevention 12 months after acute myocardial infarction. Results of the prospective GULLIVE-R study.

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Thumbnail

Infarct size, inflammatory burden and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry.

Speaker: Doctor A. Sansonetti (Bologna, IT)

Thumbnail

The effect of P2Y12 inhibitor monotherapy according to bleeding risk: a systematic review and meta-analysis

Speaker: Ms E. Woelders (Nijmegen, NL)

Thumbnail

Positive predictive value of the crusade score for bleeding events in patients with acute coronary syndromes on dual antiplatelet therapy with acetylsalicylic acid and clopidogrel

Speaker: Doctor J. Monteiro (Vila Real, PT)

Thumbnail

To pretreat or not no pretreat with dual antiplatelet therapy in non-ST elevation acute coronary syndrome patients: that is the question.

Speaker: Doctor D. Abella Vallina (Burgos, ES)

Thumbnail

Access the full session

Treatment of coronary artery disease

Speakers: Doctor E. Rexhaj, Professor U. Zeymer, Doctor A. Sansonetti, Ms E. Woelders, Doctor J. Monteiro...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk